KeyMed Biosciences
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $217M
Investors
- 32
About KeyMed Biosciences
KeyMed Biosciences was established in 2016, in Chengdu, China, with the main business of conducting medical researches. In 2019, the company was authorized to conduct clinic experiment for its CM310 program, a program developing drug against inflammations.HK. In 2022, its stock was included in Hong Kong Stock Connect. The company runs two production lines -- autoimmunity drugs and oncology drugs. There are ten drug developing programs undergoing, including nine of them already in the clinical-trail phase. The company is constructing the third production base in Chengdu, which will be put in use by June 2022.
Who invested in KeyMed Biosciences
32 investors across 4 rounds
See all investors in KeyMed Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KeyMed Biosciences
Who invested in KeyMed Biosciences?
KeyMed Biosciences has 32 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KeyMed Biosciences raised?
KeyMed Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did KeyMed Biosciences last raise money?
KeyMed Biosciences's most recent round on record is a Series C, in Feb 2021.
What does KeyMed Biosciences do?
KeyMed Biosciences was established in 2016, in Chengdu, China, with the main business of conducting medical researches.
Where is KeyMed Biosciences headquartered?
KeyMed Biosciences is headquartered in Chengdu, China.
Which VCs invest in companies like KeyMed Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at KeyMed Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like KeyMed Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.